*Clostridioides difficile* is the leading cause of antibiotic- and health care--associated diarrhea in humans \[[@CIT0001]\]. In recent decades, there has been a marked increase in the incidence and severity of CDI worldwide \[[@CIT0002]\], and community-acquired CDIs are now more common than hospital-acquired infections \[[@CIT0003], [@CIT0004]\]. Recurrent CDI (R-CDI), defined by the Infectious Diseases Society of America (IDSA) as the presence of diarrhea and a positive *C. difficile* stool assay within 2--8 weeks of the initial episode, occurs in \~20%--30% of patients with CDI \[[@CIT0005], [@CIT0006]\]. R-CDI is often poorly responsive to treatment and results in the need for additional medications, longer courses of therapy, and increased medical costs, morbidity, and mortality \[[@CIT0007]\].

Antibiotics are generally considered the primary risk factor for the development and recurrence of CDI. However, patients can develop CDI outside of a health care facility without the prior use of antibiotics, and patients who have experienced CDI can experience recurrence without additional exposure to antibiotics. In 1 study, up to 83% of people who experienced R-CDI were infected with an identical strain during recurrence \[[@CIT0008]\], suggesting that inadequate clearance of the index infection, re-infection from the original source, or re-infection from a related source could be occurring.

Carriage of *C. difficile* has been documented in many species of domesticated animals, and companion animals were posited as a potential reservoir species as early as 1983 \[[@CIT0009]\]. Overlap between strains of *C. difficile* isolated from people and animals \[[@CIT0010]\] and evidence of potential interspecies clonal transmission events of *C. difficile* \[[@CIT0010], [@CIT0013]\] have led to speculation that CDI could be a zoonotic disease. The goal of this study was to investigate whether pet ownership is a risk factor for recurrence of CDI.

METHODS {#s1}
=======

Subject Enrollment and Outcome Adjudication {#s2}
-------------------------------------------

All patients seen at the University of Pennsylvania Health System (UPHS) between January 1, 2014, and March 1, 2019, who experienced diarrhea with a positive *C. difficile* toxin assay by either polymerase chain reaction (PCR; BD Max Cdiff, Becton Dickinson, Cockeysville, MD, USA) before September 26, 2017, Xpert *C. difficile* (Cepheid, Sunnyvale, CA, USA) thereafter, or immunoassay (Cdiff Quik Chek Complete, TechLab, Blacksburg, VA, USA) were identified as potentially eligible study subjects. The study was approved by the Institutional Review Board of the University of Pennsylvania (protocol 829159).

Cases were patients with recurrent CDI, defined as a patient who had documentation of a subsequent positive *C. difficile* toxin assay within 56 days of the index CDI diagnosis or index discharge with interim resolution of symptoms \[[@CIT0014]\]. Controls were patients who did not experience a subsequent positive *C. difficile* toxin assay within 8 weeks of the index CDI diagnosis or index discharge. Only patients who continued to receive care within the UPHS for the year after initial CDI diagnosis (ie, did not die or did not transfer to another health system) were considered eligible. A history of CDI before enrollment was not an exclusion criterion. CDI was defined as health care facility onset (HFO) if the patient developed diarrhea and had a positive *C. difficile* assay \>3 days after admission \[[@CIT0015]\]. Community-onset health care facility--associated (COHFA) CDI was defined as occurring within 28 days of discharge from a health care facility \[[@CIT0015]\]. All other patients were considered to have community-acquired (CA) CDI. Patients were also classified as having either PCR + or enzyme immunoassay (EIA) + CDI, as evidence suggests that the latter group is more likely to be truly infected and the former colonized \[[@CIT0016]\].

Surveys to Ascertain Primary Exposure {#s3}
-------------------------------------

A survey instrument was adapted from a previously developed instrument \[[@CIT0017]\] to ascertain the number and species of pets in the household at the time the patient was first diagnosed with CDI, the duration of the pets' residence in the household, and the degree of contact between patients and pets. A cumulative contact score was derived as follows: The patient is the primary care provider for their pet(s) (feeding, grooming, bathing, medicating, exercising): yes = 2 points, no = 0 \[[@CIT0002]\]; the pet(s) sleep(s) in/on the human participant's bed: yes = 3 points, no = 0 \[[@CIT0003]\]; the participant allows their pet(s) to lick their face or hands: yes = 4 points; no = 0. People without pets were assigned a contact score of 0.

Potential study subjects were sent a mailing containing an introduction letter with a link to the survey, a paper copy of the survey, a printed visual aid with pictures of antibiotics to enhance recall of previously administered courses of drugs \[[@CIT0018]\], and a postage-paid return envelope. Subjects who did not return the paper survey or complete the online survey within 2 weeks were called a maximum of 2 times to participate over the phone. The control status of the subject was confirmed with a question asking the patient if he/she had been subsequently diagnosed with CDI within the established time frame at a hospital facility not in the UPHS and by verifying the medical record.

Secondary Exposure Ascertainment {#s4}
--------------------------------

The following data related to the index diagnosis of CDI were collected from the medical records: age, sex, race, ethnicity, episodes of CDI 5 years before the index diagnosis, duration of hospitalization of inpatients, comorbidities used to calculate the Charlson comorbidity score or associated with CDI (eg, inflammatory bowel disease), gastric acid suppression or immunosuppression at the time of the index diagnosis, whether the patient was hospitalized within a month before admission or after discharge, and antibiotics prescribed before and during/after the index diagnosis. A Charlson comorbidity score was calculated for each patient.

Statistical Analysis {#s5}
--------------------

Descriptive analyses included computation of means with 95% confidence intervals (95% CIs), standard deviations, medians, interquartile ranges (IQRs) of continuous variables, and tabulation of categorical variables. Categorical variables were compared between cases and controls using the chi-square test, and continuous variables were compared using the Student *t* or Wilcoxon rank-sum test as appropriate. Bivariable analysis was conducted to determine the unadjusted association between potential risk factors (pet ownership, number of pets, and pet contact score) and R-CDI. Variables that represented putative risk factors for recurrence, variables trending to be associated with R-CDI on bivariable analysis (*P* \< 0.15), and variables involved in confounding the association between pet ownership and recurrence of CDI (ie, their inclusion in the model resulted in a \>15% change in the effect size of the primary association of interest) were added to the model in a step-wise fashion. Stratified analyses were performed post hoc by infection type (eg, health care facility--onset vs community-acquired/community-onset CDI) and diagnostic assay type (PCR+ vs EIA+). Statistical interactions between key variables were assessed by performing stratified analyses. Model fits were examined using Aikaike Information Criteria. All analyses were conducted with Stata 15 (StataCorp, State College, TX, USA), with 2-sided tests of hypotheses and a *P* value \<0.05 as the criterion for statistical significance.

RESULTS {#s6}
=======

Survey Response {#s7}
---------------

A total of 750 survey invitations were sent to prospective participants. Of those, 56 were returned unopened to the sender for having an incorrect address. One hundred eleven participants completed the paper or online survey, whereas 120 participated over the phone, for a total of 231 completed surveys (response rate of 31%). The remaining participants either declined to participate (n = 35), died (n = 14), or could not be reached by phone (n = 414). Characteristics of responders and nonresponders are presented in [Supplementary Table 1](#sup1){ref-type="supplementary-material"}.

Subject Characteristics {#s8}
-----------------------

Of the 232 completed surveys, 86 were from cases (ie, people who had experienced recurrent CDI within 56 days) and 146 were from controls (ie, people who did not experience recurrence of CDI). Health care facility--onset cases accounted for 104 cases (45.0%), community-onset health care facility--acquired cases accounted for 27 cases (11.7%), and community-associated accounted for 101 cases (43.3%). The duration between the index diagnosis and recurrence for cases is shown in [Figure 1](#F1){ref-type="fig"}.

![Distribution of the duration between index diagnosis and recurrence for 86 patients who experienced recurrent *Clostridioides difficile* infection at the University of Pennsylvania Health System (Philadelphia, PA, USA).](ofz541f0001){#F1}

Demographic information is shown for all patients and patients with community-onset or community-acquired CDI in [Table 1](#T1){ref-type="table"}. There were no significant differences in any demographic parameters between cases and controls. Most (80%) of the patients had been administered antimicrobials before developing the index episode of CDI, and almost all (98%) of the patients who experienced CDI were treated with antimicrobials. The only parameters that were significantly associated with being a case for all patients were prior episodes of CDI (*P* = 0.003) and subsequent additional hospitalization either a month before (*P* = 0.010) or after (*P* = 0.001) the index visit. Among patients with community-acquired or community-onset CDI, only the Charlson comorbidity index (*P* = 0.040) and pet ownership (*P* = 0.083) were significantly and borderline significantly associated with being a case, respectively.

###### 

Demographic and Clinical Characteristics of 232 Patients who Experienced Recurrent *Clostridioides difficile* Infection (Cases) and Patients who Did Not Experience Recurrent *Clostridioides difficile* Infection (Controls)

                                                                               All Patients (n = 232)   Patients With Community-Acquired or Community-Onset *C. difficile* Infection (n = 131)                                        
  ---------------------------------------------------------------------------- ------------------------ ---------------------------------------------------------------------------------------- -------- ------------- ------------- -------
  Sex, No. (%)                                                                                                                                                                                                                        
   Female                                                                      93 (63.7)                47 (54.7)                                                                                0.174    63 (71.6)     26 (67.9)     0.200
   Male                                                                        53 (36.6)                39 (45.4)                                                                                         25 (28.4)     17 (39.5)     
  Mean (SD) age, y                                                             56.1 (16.1)              57.8 (16.8)                                                                              0.463    53.7 (16.8)   58.2 (17.6)   0.164
  Race, No. (%)                                                                                                                                                                                                                       
   White                                                                       107 (75.4)               67 (77.9)                                                                                0.832    66 (77.7)     32 (74.4)     0.196
   Black                                                                       30 (21.1)                17 (19.8)                                                                                         16 (18.8)     9 (20.9)      
   Asian                                                                       5 (3.6)                  2 (2.3)                                                                                           3 (3.5)       2 (4.7)       
  Ethnicity, No. (%)                                                                                                                                                                                                                  
   Non-Hispanic                                                                138 (97.2)               82 (95.4)                                                                                0.466    82 (96.5)     41 (95.4)     0.757
   Hispanic                                                                    4 (2.8)                  4 (3.5)                                                                                           3 (3.5)       2 (4.7)       
  Median (IQR) length of stay among inpatients, d                              9 (3--20)                8 (4--18)                                                                                0.943    3 (1--5)      4 (3--7)      0.198
  Mean (SD) Charlson comorbidity index score                                   4.12 (2.71)              4.41 (2.74)                                                                              0.414    3.3 (2.6)     4.3 (3.0)     0.040
  Experienced prior episodes of CDI within previous 5 y, No. (%)               9 (6.2)                  15 (17.4)                                                                                0.003    7 (8.0)       7 (16.3)      0.148
  Inflammatory bowel disease, No. (%)                                          22 (15.2)                15 (17.4)                                                                                0.649    20 (22.7)     11 (25.6)     0.718
  Received antibiotics before CDI diagnosis, No. (%)                           110 (78.0)               71 (82.6)                                                                                0.409    66 (76.7)     35 (81.4)     0.546
  Gastric acid suppression, No. (%)                                            83 (57.2)                42 (48.8)                                                                                0.215    44 (50.0)     18 (41.9)     0.381
  Immunosuppression, No. (%)                                                   54 (37.2)                31 (36.1)                                                                                0.856    16 (29.1)     11 (28.2)     0.925
  Additional hospitalization before index diagnosis/hospitalization, No. (%)   34 (23.5)                34 (39.5)                                                                                0.010    16 (18.2)     11 (25.6)     0.326
  Additional hospitalization after index diagnosis/hospitalization, No. (%)    24 (17.0)                33 (38.4)                                                                                0.001    14 (15.9)     9 (20.9)      0.478
  Pet ownership, No. (%)                                                       73 (50.4)                39 (45.4)                                                                                0.4363   51 (58.0)     18 (41.9)     0.083

Abbreviations: CDI, *Clostridioides difficile* infection; IQR, interquartile range.

Relationship Between Pet Ownership and CDI Recurrence Risk {#s9}
----------------------------------------------------------

A total of 112 (48.3%) respondents were pet owners, which is slightly lower than the national average of 57% \[[@CIT0019]\]. Among the 112 pet owners, 56 (50.0%) owned dogs only, 26 (23.2%) owned cats only, 23 (20.5%) owned dogs and cats, and 6 (2.3%) owned a combination of cats, dogs, and other species (including birds, rabbits, and hamsters). The mean (SD) contact score among pet owners was 4.3 (2.2) points, out of a possible total of 7 (non--pet owners had a score of 0).

Univariable analysis showed no significant association between pet ownership and recurrence of CDI (odds ratio \[OR\], 0.83; 95% CI, 0.49--1.42) ([Table 2](#T2){ref-type="table"}), regardless of whether patients had EIA+ or PCR+ toxin tests (OR, 0.70; 95% CI, 0.30--1.62; vs OR, 0.92; 95% CI, 0.45--1.86) ([Supplementary Table 1](#sup1){ref-type="supplementary-material"}). A modest but nonsignificant dose--response association between degree of contact between pets and protection against recurrence of CDI was observed: For every point increase in the contact score, the odds of experiencing recurrence decreased by 3.5% (OR, 0.96; 95% CI, 0.87--1.07). The total number of pets within a household was not associated with recurrence (OR, 1.03; 95% CI, 0.90--1.18).

###### 

Association Between Pet Ownership, Pet Contact, Patient Factors, and Recurrence of *Clostridioides difficile* Infection (n = 232)

                                                                    Univariable Analysis   Multivariable Analysis                               
  ----------------------------------------------------------------- ---------------------- ------------------------ ------- ------ ------------ -------
  Pet ownership                                                     0.81                   0.47--1.38               0.432   1.02   0.38--2.72   0.965
  Pet contact score (0--7 points)                                   0.96                   0.87--1.06               0.435   0.98   0.81--1.18   0.802
  Prior CDI                                                         3.22                   1.34--7.71               0.009   2.97   1.20--7.37   0.019
  Additional hospitalization 1 mo before index diagnosis            2.15                   1.21--3.84               0.009   2.03   1.02--3.48   0.042
  Additional hospitalization 1 mo after index diagnosis/discharge   2.62                   1.44--4.78               0.002   2.30   1.23--4.31   0.009

Abbreviations: CDI, *Clostridioides difficile* infection; CI, confidence interval.

Multivariable analysis controlling for previous CDI and additional hospitalization (1 month before or after the index visit) showed no significant association between pet ownership and recurrence risk (OR, 0.93; *P* = 0.53--1.63) ([Table 2](#T2){ref-type="table"}).

Stratification by Type of Infection {#s10}
-----------------------------------

We then conducted stratified analyses post hoc based on whether the CDI was HFA or CA/CO-HFA. In contrast to the hypothesized relationship, we found that pet ownership and the pet contact score were borderline significantly and significantly protective, respectively, against recurrence among patients with CA or CO-HFA CDI (OR for pet ownership, 0.54; 95% CI, 0.23--1.12; and OR for contact score, 0.84; 95% CI, 0.72--0.97) ([Table 3](#T3){ref-type="table"}). These relationships persisted in analyses restricted to patients with either an EIA+ or PCR+ diagnosis of CDI ([Supplementary Table 2](#sup2){ref-type="supplementary-material"}). When adjusting for the Charlson comorbidity index ([Table 3](#T3){ref-type="table"}), pet ownership remained protective against recurrence, though the effect was no longer statistically significant (OR, 0.60; 95% CI, 0.27--1.24), and the contact score was borderline significantly protective against recurrence (OR, 0.86; 95% CI, 0.74--1.00). The distribution of cases, controls, and pet ownership among patients with or without prior CDI is shown in [Supplementary Table 3](#sup3){ref-type="supplementary-material"}.

###### 

Association Between Pet Ownership, Pet Contact, Patient Factors, and Recurrence of *Clostridioides difficile* Infection Among Patients With Community-Onset or Community-Acquired *C. difficile* Infection (n = 131)

                                    Univariable Analysis   Multivariable Analysis                                
  --------------------------------- ---------------------- ------------------------ ------- ------ ------------- -------
  Pet ownership                     0.52                   0.25--1.09               0.085   0.58   0.27--1.24    0.163
  Pet contact score (0--7 points)   0.84                   0.72--0.97               0.022   0.86   0.74--1.00    0.051
  Charlson comorbidity index        1.15                   1.00--1.32               0.040   1.12   0.976--1.29   0.105

Abbreviation: CI, confidence interval.

DISCUSSION {#s11}
==========

Consistent with other studies, we found that prior episodes of CDI \[[@CIT0020]\], hospitalization both before or after the index diagnosis \[[@CIT0021]\], and increasing Charlson score \[[@CIT0022]\] were risk factors for recurrence. Somewhat unexpectedly, though, we found that pet ownership and increasing contact with pets were not associated with recurrence of CDI, but instead were protective against recurrence among patients with CA or CO-HFA CDI.

Pets are recognized reservoirs of bacterial pathogens that can be transferred to owners via the fecal--oral pathway \[[@CIT0023]\], and healthy dogs and cats have been shown to shed *C. difficile* at rates of 3.4%--5.5% and 2.5%--3.4%, respectively \[[@CIT0024], [@CIT0025]\]. Pet owners frequently engage in activities that could facilitate such a transfer (eg, close contact, allowing pet to lick hands and face, picking up fecal matter, sleeping with pet), whereas pets engage in behavior that could allow them to become colonized with pathogens (eg, coprophagia, drinking from contaminated places such as toilets, close contact with the ground, licking paws, etc.). Although no studies have demonstrated the direct transmission of *C. difficile* between pets and their owners, 1 study found that 2/9 (22%) cats and 2/5 (40%) dogs belonging to owners who had experienced CDI carried *C. difficile* with identical PFGE profiles as their owners \[[@CIT0026]\], and other studies have presented varying degrees of evidence suggesting that dogs could represent a reservoir of *C. difficile* \[[@CIT0027], [@CIT0028]\]. Less work has been done in cats, but cats have also been found to be colonized with *C. difficile*. We therefore originally hypothesized that a patient who had experienced CDI could transmit *C. difficile* to a pet, which could then act as a reservoir for recurrence of *C. difficile* in the index patient or colonization of people who did not carry the pathogen. As with other diseases such as methicillin-resistant *Staphylococcus aureus* \[[@CIT0017]\], we supposed that asymptomatic pet carriers could represent a major source of infection and/or cyclical re-infection. The opposite finding---that pet ownership was protective against recurrence---was unexpected. Interestingly, the protective effect of pet ownership was stronger among EIA+ patients, who are more likely to be truly infected \[[@CIT0016]\], than among patients with PCR+ assays, who are more likely to be colonized. This suggests that the protective effects of pet ownership and pet contact are real and not due to confounding by colonization (and therefore less severe illness).

The effects of certain risk factors for CDI and RCDI are likely mediated by their disruptive effect on the gut microbiota \[[@CIT0029]\]. Disruption of the gut microbiota results in reduced microbial diversity, development of opportunistic species, and loss of resistance to colonization \[[@CIT0029], [@CIT0030]\]. Pets have been shown to significantly alter the microbial communities of household environments \[[@CIT0031], [@CIT0032]\], which, in turn, can alter the gut microbiota of people living in the household \[[@CIT0033]\]. For example, exposure to pets can alter the gut microbiota of infants in ways that are beneficial in preventing childhood atopy, obesity, asthma, and food allergies \[[@CIT0034]\]. Dog ownership can also significantly increase the shared skin microbiota in cohabiting adults \[[@CIT0037]\], suggesting that pets transfer microbiota to their owners. As such, pets may provide microbiota that can increase resistance against the recurrence of CDI. In support, increasing contact between patients and pets, as quantified by the pet contact score, was significantly associated with protection against recurrence. However, more research is needed to verify this hypothesis.

It is unclear why the protective effect of pet ownership was only significant among patients with CA or CO-HFA CDI. These patients were less likely to have experienced additional hospitalizations before or after their index diagnosis and therefore may have had increased exposure to their pets following their index diagnosis. Additionally, because patients with community-acquired CDI may be more prone to recurrence than patients with health care facility--onset CDI \[[@CIT0038]\], it is possible that protective factors such as pet ownership have a more pronounced effect among these patients than among patients with health care facility--onset CDI.

This study had several limitations. First, because this was a retrospective study and because CDI was diagnosed using molecular methods rather than culture, we were unable to identify the strain of *C. difficile*. Certain strains, most notably Ribotype 027, are associated with recurrence \[[@CIT0039]\], and it is possible that the strain with which patients were infected could better explain the risk of recurrence than pet ownership. Second, because some of the index diagnoses occurred several years ago, patients may have had limited recall of the circumstances surrounding their diagnosis. However, we do not believe that pet ownership is something that is easily forgotten, even if it occurred several years ago. Third, patients may have had varying durations of antibiotic therapy following diagnosis of CDI, which could have impacted the likelihood of recurrence. Although no difference in the rate of recurrence has been found for patients treated with metronidazole vs vancomycin \[[@CIT0040]\], little is known about the effect of therapy duration on recurrence \[[@CIT0041]\], and guidelines for the treatment of CDI propose ranges of durations for antibiotic therapy \[[@CIT0042]\]. Fourth, the results of the study may not be generalizable because of the relatively small study size, the low response rate (31%), and the fact that it was conducted at a single institution. Moreover, because nonresponders were significantly different from responders in several respects ([Supplementary Table 2](#sup2){ref-type="supplementary-material"}), the results may be subject to bias. Specifically, because responders were significantly more likely to have experienced prior episodes of CDI, recurrence of CDI, and gastric acid suppression, they may have been more invested in contributing to research aimed at better understanding the epidemiology of their condition. Finally, cases with short durations between the index diagnosis and the subsequent positive test may have been experiencing relapse rather than recurrence \[[@CIT0008]\], which are 2 different biological phenomena and could have different contributing risk factors. However, to mitigate this possibility, the UPHS only allows the submission of repeat *C. difficile* assays after 9 days have elapsed since the first assay. Future studies should aim to examine the relationship between pet ownership and recurrence of CDI prospectively and more closely assess the gut microbial ecology of pet owners with and without pets.

CONCLUSIONS {#s12}
===========

Although more research is needed to understand the transmission dynamics of *C. difficile* within a household and between pets and owners, it appears that pet ownership and close contact with pets are not associated with recurrence of CDI and may instead be protective against recurrence of CDI in patients with community-acquired or community-onset CDI.

Supplementary Data {#s13}
==================

Supplementary materials are available at *Open Forum Infectious Diseases* online. Consisting of data provided by the authors to benefit the reader, the posted materials are not copyedited and are the sole responsibility of the authors, so questions or comments should be addressed to the corresponding author.
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